Trials / Active Not Recruiting
Active Not RecruitingNCT02307630
PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot Study
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 3 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to find out how an antibody called Hu3F8 travels through the body and to tumors. Antibodies, like Hu3F8, are proteins that help attack tumors or fight infections. Antibodies can be made by your own body or in a laboratory. The target of an antibody is called an antigen; antibodies fit their antigen like a lock fits a key.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | 124I-Humanized 3F8 |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2026-11-01
- Completion
- 2026-11-01
- First posted
- 2014-12-04
- Last updated
- 2025-12-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02307630. Inclusion in this directory is not an endorsement.